Codes / ICD10CM / T38.2X

T38.2X Poisoning by, adverse effect of and underdosing of antithyroid drugs

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by, adverse effect of and underdosing of antithyroid drugs

Summary

This condition encompasses poisoning, adverse effects, or underdosing related to antithyroid drugs. These medications are used to treat hyperthyroidism, and the code covers clinical scenarios where their use leads to harmful outcomes or insufficient therapeutic effect.

Causes

The causes include accidental or intentional overdose of antithyroid drugs, adverse reactions to prescribed or non-prescribed use, or inadequate dosing that fails to achieve the intended therapeutic effect. Underdosing may result from missed doses, incorrect administration, or subtherapeutic prescribing.

Risk Factors

  • Use of antithyroid drug therapies for hyperthyroidism
  • Polypharmacy involving antithyroid agents
  • Incorrect dosing or administration
  • Individual sensitivity to antithyroid substances
  • Renal or hepatic impairment affecting drug metabolism

Symptoms

Symptoms vary based on the specific agent and scenario: poisoning may cause hypothyroidism (e.g., fatigue, weight gain, cold intolerance); adverse effects can include allergic reactions or organ-specific toxicity; underdosing may lead to unresolved hyperthyroidism (e.g., tachycardia, tremors, heat intolerance).

Diagnosis

Diagnosis relies on a thorough medication history, clinical evaluation of symptoms, and laboratory tests to assess thyroid function and drug levels. Documentation should specify the type of antithyroid drug involved and the nature of the event (poisoning, adverse effect, or underdosing).

Treatment Options

Treatment depends on the severity and type of event. For poisoning or adverse effects, management may include discontinuation of the drug, supportive care, and specific antidotes if available. Underdosing may require dose adjustment or alternative therapies to achieve therapeutic goals.

Prognosis and Follow-Up

Prognosis varies based on the extent of exposure and timely intervention. Regular follow-up is essential to monitor thyroid function and adjust treatment as needed. Long-term outcomes depend on the resolution of symptoms and prevention of recurrence.

Complications

Complications may include severe hypothyroidism or hyperthyroidism, organ damage from toxicity, or treatment-resistant symptoms. Early recognition and management reduce the risk of adverse outcomes.

Lifestyle & Prevention

Patients should adhere to prescribed dosing regimens and avoid self-adjusting medications. Educate on proper storage and handling of antithyroid drugs to prevent accidental ingestion. Regular monitoring of thyroid function helps detect issues early.

When to Seek Professional Help

Seek immediate medical attention for symptoms of severe hypothyroidism or hyperthyroidism, such as chest pain, difficulty breathing, or altered mental status. Contact a healthcare provider for persistent or worsening symptoms related to antithyroid drug use.

Tips for Medical Coders

Document the specific antithyroid drug involved and the nature of the event (poisoning, adverse effect, or underdosing) to support accurate coding. Ensure clinical details align with the code’s definition to avoid miscoding.

Book a walkthrough

T38.2X policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.